Short Interest in EV Biologics, Inc. (OTCMKTS:YECO) Declines By 50.0%

EV Biologics, Inc. (OTCMKTS:YECO) was the target of a significant drop in short interest in February. As of February 15th, there was short interest totalling 100 shares, a drop of 50.0% from the January 31st total of 200 shares. Based on an average daily volume of 17,300 shares, the short-interest ratio is currently 0.0 days.

EV Biologics Price Performance

Shares of OTCMKTS YECO opened at $0.09 on Friday. The company has a 50 day simple moving average of $0.12 and a two-hundred day simple moving average of $0.20. EV Biologics has a fifty-two week low of $0.09 and a fifty-two week high of $0.99.

EV Biologics Company Profile

EV Biologics, Inc, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.